XPERI INC (XPER) Stock Fundamental Analysis
NYSE:XPER - New York Stock Exchange, Inc. - US98423J1016 - Common Stock - Currency: USD
XPER gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 282 industry peers in the Software industry. The financial health of XPER is average, but there are quite some concerns on its profitability. XPER is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year XPER was profitable.
XPER had a negative operating cash flow in the past year.
In the past 5 years XPER always reported negative net income.
XPER had negative operating cash flow in 4 of the past 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of -3.04%, XPER is in line with its industry, outperforming 54.26% of the companies in the same industry.
XPER has a Return On Equity (-4.60%) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -3.04% | ||
| ROE | -4.6% | ||
| ROIC | N/A |
ROA(3y)-41.72%
ROA(5y)-29.98%
ROE(3y)-66.84%
ROE(5y)-46.08%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
XPER's Gross Margin of 76.76% is fine compared to the rest of the industry. XPER outperforms 72.69% of its industry peers.
XPER's Gross Margin has declined in the last couple of years.
XPER does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 76.76% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.23%
GM growth 5Y-4.34%
2. Health
2.1 Basic Checks
XPER does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for XPER has been increased compared to 1 year ago.
Compared to 5 years ago, XPER has less shares outstanding
XPER has a worse debt/assets ratio than last year.
2.2 Solvency
XPER has an Altman-Z score of -0.19. This is a bad value and indicates that XPER is not financially healthy and even has some risk of bankruptcy.
XPER has a Altman-Z score of -0.19. This is in the lower half of the industry: XPER underperforms 72.34% of its industry peers.
XPER has a Debt/Equity ratio of 0.10. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.10, XPER is in line with its industry, outperforming 54.61% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.1 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -0.19 |
ROIC/WACCN/A
WACC10.82%
2.3 Liquidity
A Current Ratio of 2.27 indicates that XPER has no problem at all paying its short term obligations.
With a decent Current ratio value of 2.27, XPER is doing good in the industry, outperforming 67.38% of the companies in the same industry.
XPER has a Quick Ratio of 2.26. This indicates that XPER is financially healthy and has no problem in meeting its short term obligations.
XPER's Quick ratio of 2.26 is fine compared to the rest of the industry. XPER outperforms 67.38% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.27 | ||
| Quick Ratio | 2.26 |
3. Growth
3.1 Past
XPER shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 1172.73%, which is quite impressive.
XPER shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -21.24% yearly.
Looking at the last year, XPER shows a decrease in Revenue. The Revenue has decreased by -4.77% in the last year.
The Revenue has been growing by 20.04% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)1172.73%
EPS 3Y-21.82%
EPS 5Y-21.24%
EPS Q2Q%420%
Revenue 1Y (TTM)-4.77%
Revenue growth 3Y0.49%
Revenue growth 5Y20.04%
Sales Q2Q%-4.05%
3.2 Future
Based on estimates for the next years, XPER will show a very strong growth in Earnings Per Share. The EPS will grow by 20.68% on average per year.
The Revenue is expected to grow by 3.33% on average over the next years.
EPS Next Y3.68%
EPS Next 2Y20.68%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-1.78%
Revenue Next 2Y3.33%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 6.61, the valuation of XPER can be described as very cheap.
Based on the Price/Earnings ratio, XPER is valued cheaper than 95.74% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.30. XPER is valued rather cheaply when compared to this.
The Price/Forward Earnings ratio is 5.52, which indicates a rather cheap valuation of XPER.
Compared to the rest of the industry, the Price/Forward Earnings ratio of XPER indicates a rather cheap valuation: XPER is cheaper than 97.52% of the companies listed in the same industry.
XPER is valuated cheaply when we compare the Price/Forward Earnings ratio to 21.76, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 6.61 | ||
| Fwd PE | 5.52 |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
XPER's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
XPER's earnings are expected to grow with 20.68% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.8
PEG (5Y)N/A
EPS Next 2Y20.68%
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for XPER!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
7.8
-0.17 (-2.13%)
Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)
Earnings (Next)
Inst Owners90.14%
Inst Owner Change0%
Ins Owners3.11%
Ins Owner Change14.2%
Market Cap356.38M
Analysts84
Price Target18.61 (138.59%)
Short Float %4%
Short Ratio5.47
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)338.09%
Min EPS beat(2)63.17%
Max EPS beat(2)613.01%
EPS beat(4)3
Avg EPS beat(4)205.96%
Min EPS beat(4)-33.78%
Max EPS beat(4)613.01%
EPS beat(8)7
Avg EPS beat(8)129.66%
EPS beat(12)11
Avg EPS beat(12)111.25%
EPS beat(16)14
Avg EPS beat(16)91.5%
Revenue beat(2)0
Avg Revenue beat(2)-2.22%
Min Revenue beat(2)-3.16%
Max Revenue beat(2)-1.28%
Revenue beat(4)0
Avg Revenue beat(4)-3.77%
Min Revenue beat(4)-10.31%
Max Revenue beat(4)-0.34%
Revenue beat(8)0
Avg Revenue beat(8)-3.33%
Revenue beat(12)1
Avg Revenue beat(12)-6.41%
Revenue beat(16)1
Avg Revenue beat(16)-16.57%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-15.02%
EPS NY rev (1m)0%
EPS NY rev (3m)9.8%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.37%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.23%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 6.61 | ||
| Fwd PE | 5.52 | ||
| P/S | 0.73 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 0.85 | ||
| P/tB | 1.35 | ||
| EV/EBITDA | N/A |
EPS(TTM)1.18
EY15.13%
EPS(NY)1.41
Fwd EY18.11%
FCF(TTM)-0.97
FCFYN/A
OCF(TTM)-0.61
OCFYN/A
SpS10.7
BVpS9.17
TBVpS5.8
PEG (NY)1.8
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -3.04% | ||
| ROE | -4.6% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 76.76% | ||
| FCFM | N/A |
ROA(3y)-41.72%
ROA(5y)-29.98%
ROE(3y)-66.84%
ROE(5y)-46.08%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.23%
GM growth 5Y-4.34%
F-Score4
Asset Turnover0.77
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.1 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 30.87% | ||
| Cap/Sales | 3.41% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.27 | ||
| Quick Ratio | 2.26 | ||
| Altman-Z | -0.19 |
F-Score4
WACC10.82%
ROIC/WACCN/A
Cap/Depr(3y)21.67%
Cap/Depr(5y)15.65%
Cap/Sales(3y)2.93%
Cap/Sales(5y)2.5%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1172.73%
EPS 3Y-21.82%
EPS 5Y-21.24%
EPS Q2Q%420%
EPS Next Y3.68%
EPS Next 2Y20.68%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-4.77%
Revenue growth 3Y0.49%
Revenue growth 5Y20.04%
Sales Q2Q%-4.05%
Revenue Next Year-1.78%
Revenue Next 2Y3.33%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y45.51%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year743.63%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y33.72%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y47.71%
OCF growth 3YN/A
OCF growth 5YN/A